Clinical Study

Trabectedin Followed by Irinotecan Can Stabilize Disease in Advanced Translocation-Positive Sarcomas with Acceptable Toxicity

Figure 1

Treatment plan. Duration of cycle: 21 days. Response evaluation: after 2 cycles.